199 related articles for article (PubMed ID: 19134356)
1. [Roles of matrix metalloproteinases and tissue specific inhibitors of metalloproteinases in dentinogenic ghost cell tumor and ghost cell odontogenic carcinoma].
Geng N; Ban Y; Chen Y; Yang MZ; Bao DM; Yi XZ
Zhonghua Kou Qiang Yi Xue Za Zhi; 2008 Dec; 43(12):756-60. PubMed ID: 19134356
[TBL] [Abstract][Full Text] [Related]
2. Ghost cell odontogenic carcinoma transformed from a dentinogenic ghost cell tumor of maxilla after multiple recurrences.
Li BB; Gao Y
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 May; 107(5):691-5. PubMed ID: 19272810
[TBL] [Abstract][Full Text] [Related]
3. International collaborative study on ghost cell odontogenic tumours: calcifying cystic odontogenic tumour, dentinogenic ghost cell tumour and ghost cell odontogenic carcinoma.
Ledesma-Montes C; Gorlin RJ; Shear M; Prae Torius F; Mosqueda-Taylor A; Altini M; Unni K; Paes de Almeida O; Carlos-Bregni R; Romero de León E; Phillips V; Delgado-Azañero W; Meneses-García A
J Oral Pathol Med; 2008 May; 37(5):302-8. PubMed ID: 18221328
[TBL] [Abstract][Full Text] [Related]
4. Peripheral dentinogenic ghost cell tumor: a case report and review of the literature.
Candido GA; Viana KA; Watanabe S; Vencio EF
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Sep; 108(3):e86-90. PubMed ID: 19716497
[TBL] [Abstract][Full Text] [Related]
5. Comparative Analysis Between Dentinogenic Ghost Cell Tumor and Ghost Cell Odontogenic Carcinoma: A Systematic Review.
de Souza Vieira G; de Pinho Montovani P; Rozza-de-Menezes RE; Cunha KSG; Conde DC
Head Neck Pathol; 2021 Dec; 15(4):1265-1283. PubMed ID: 34128137
[TBL] [Abstract][Full Text] [Related]
6. The expression of NF-kappaB, Ki-67 and MMP-9 in CCOT, DGCT and GCOC.
Gong Y; Wang L; Wang H; Li T; Chen X
Oral Oncol; 2009 Jun; 45(6):515-20. PubMed ID: 18723387
[TBL] [Abstract][Full Text] [Related]
7. The expression of apoptotic proteins and matrix metalloproteinases in odontogenic myxomas.
Bast BT; Pogrel MA; Regezi JA
J Oral Maxillofac Surg; 2003 Dec; 61(12):1463-6. PubMed ID: 14663812
[TBL] [Abstract][Full Text] [Related]
8. Correlation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase expression in ileal carcinoids, lymph nodes and liver metastasis with prognosis and survival.
Voland P; Besig S; Rad R; Braun T; Baur DM; Perren A; Langer R; Höfler H; Prinz C
Neuroendocrinology; 2009; 89(1):66-78. PubMed ID: 18708724
[TBL] [Abstract][Full Text] [Related]
9. The diagnosis and treatment of dentinogenic ghost cell tumor.
Sun G; Huang X; Hu Q; Yang X; Tang E
Int J Oral Maxillofac Surg; 2009 Nov; 38(11):1179-83. PubMed ID: 19619984
[TBL] [Abstract][Full Text] [Related]
10. Expression of matrix metalloproteinases-1, -2, and -9; tissue inhibitors of matrix metalloproteinases-1 and -2; cathepsin B; urokinase plasminogen activator; and plasminogen activator inhibitor, type I in skull base chordoma.
Naka T; Kuester D; Boltze C; Schulz TO; Samii A; Herold C; Ostertag H; Roessner A
Hum Pathol; 2008 Feb; 39(2):217-23. PubMed ID: 17949787
[TBL] [Abstract][Full Text] [Related]
11. A recurrent case of odontogenic ghost cell tumour of the mandible.
Kasahara K; Iizuka T; Kobayashi I; Totsuka Y; Kohgo T
Int J Oral Maxillofac Surg; 2002 Dec; 31(6):684-7. PubMed ID: 12521331
[TBL] [Abstract][Full Text] [Related]
12. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Sakata K; Shigemasa K; Nagai N; Ohama K
Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinases in carcinoma of unknown primary.
Karavasilis V; Malamou-Mitsi V; Briasoulis E; Tsanou E; Kitsou E; Kalofonos H; Fountzilas G; Fotsis T; Pavlidis N
Cancer; 2005 Nov; 104(10):2282-7. PubMed ID: 16220559
[TBL] [Abstract][Full Text] [Related]
14. Expression of matrix metalloproiteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in hepatocellular carcinoma tissue, compared with the surrounding non-tumor tissue.
Matsunaga Y; Koda M; Murawaki Y
Res Commun Mol Pathol Pharmacol; 2004; 115-116():143-50. PubMed ID: 17564313
[TBL] [Abstract][Full Text] [Related]
15. Ghost cell odontogenic carcinoma arising in dentinogenic ghost cell tumor, peripheral: A case report.
Sakamoto S; Ando T; Mizuta K; Ono S; Konishi M; Miyauchi M; Ogawa I
Pathol Int; 2023 Aug; 73(8):367-372. PubMed ID: 37401869
[TBL] [Abstract][Full Text] [Related]
16. A lesion categorized between ghost cell odontogenic carcinoma and dentinogenic ghost cell tumor with CTNNB1 mutation.
Ohata Y; Kayamori K; Yukimori A; Sumikura K; Ohsako T; Harada H; Sakamoto K; Ikeda T
Pathol Int; 2018 May; 68(5):307-312. PubMed ID: 29575443
[TBL] [Abstract][Full Text] [Related]
17. [Immunohistochemical localization of matrix metalloproteinases (MMP) and tissue inhibitors of metalloproteinases (TIMP) in tuberculous pleuritis].
Hoheisel G; Sack U; Hui DS; Lai F; Chan KS; Choi CH; Schauer J; Tannapfel A
Pneumologie; 2004 May; 58(5):305-8. PubMed ID: 15162254
[TBL] [Abstract][Full Text] [Related]
18. The dentinogenic ghost cell tumor.
Tajima Y; Ohno J; Utsumi N
J Oral Pathol; 1986 Jul; 15(6):359-62. PubMed ID: 3093655
[TBL] [Abstract][Full Text] [Related]
19. Ghost cell odontogenic carcinoma.
Nazaretian SP; Schenberg ME; Simpson I; Slootweg PJ
Int J Oral Maxillofac Surg; 2007 May; 36(5):455-8. PubMed ID: 17141471
[TBL] [Abstract][Full Text] [Related]
20. Ghost cell odontogenic carcinoma arising in the background of a benign calcifying cystic odontogenic tumor of the mandible.
Arashiyama T; Kodama Y; Kobayashi T; Hoshina H; Takagi R; Hayashi T; Cheng J; Saku T
Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Sep; 114(3):e35-40. PubMed ID: 22862988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
